logo
  

UnitedHealth Group Affirms FY22 Outlook; Q4 Results Top Estimates - Quick Facts

While reporting financial results for the fourth quarter and fiscal 2021 on Wednesday, diversified health care company UnitedHealth Group, Inc. (UNH) affirmed its earnings and revenue outlook for the full-year 2022.

For fiscal 2022, UnitedHealth Group continues to project net earnings in the range of $20.20 to $20.70 per share and adjusted net earnings in the range of $21.10 to $21.60 per share on revenues between $317 billion and $320 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $21.65 per share on revenues of $317.27 billion for the year. Analysts' estimates typically exclude special items.

For the fourth quarter, net earnings attributable to common shareholders almost doubled to $4.07 billion or $4.26 per share from $2.21 billion or $2.30 per share in the prior-year quarter.

Excluding items, adjusted earnings for the quarter were $4.48 per share, compared to $2.52 per share in the year-ago quarter.

Revenues for the quarter grew to $73.74 billion from $65.46 billion in the same quarter last year.

The Street was looking for earnings of $4.31 per share on revenues of $72.75 billion for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The TJX Companies, Inc. (TJX) said its first-quarter pretax profit margin and earnings per share, each on an adjusted basis, exceeded its plans even though sales were slightly below planned range. Adjusted pretax margin was 9.4%, excluding a 1.9 percentage point charge related to a write-down of the... Apple Inc. is delaying its latest plan to ask employees to come back to the office three days a week, but will continue with its plan of two days in office a week, Bloomberg reported. Citing an internal memo, the report also said the tech major is again requiring its staff to wear masks in common spaces, meeting rooms, hallways, and elevators, as well as at 100 US stores. The U.S. Food and Drug Administration or FDA has urged infant formula manufacturers to import infant formula products to the United States to meet the ongoing severe supply shortage. In order to further increase the availability of infant formula in the country, while protecting the health of infants, the regulator announced a guidance outlining increased flexibilities for the global manufacturers
Follow RTT